(Q40666371)

22 September 2017

title

Analysis of HLA-E expression in human tumors (English)

1 reference

22 September 2017

7

Federico Garrido

1 reference

22 September 2017

Rosario Marín

1

1 reference

22 September 2017

Francisco Ruiz-Cabello

2

1 reference

22 September 2017

Susana Pedrinaci

3

1 reference

22 September 2017

Rosa Méndez

4

1 reference

22 September 2017

Pilar Jiménez

5

1 reference

22 September 2017

Daniel E Geraghty

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

30 January 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

54

1 reference

22 September 2017

issue

11

1 reference

22 September 2017

page(s)

767-775

1 reference

MHC antigens and tumor escape from immune surveillance

22 September 2017

cites work

1 reference

12 December 2020

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

1 reference

12 December 2020

Viral strategies of immune evasion

1 reference

12 December 2020

Cell surface expression of HLA-E: interaction with human beta2-microglobulin and allelic differences

1 reference

12 December 2020

Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy

1 reference

12 December 2020

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

12 December 2020

Multiple mechanisms underlie HLA dysregulation in cervical cancer

1 reference

12 December 2020

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

12 December 2020

Criteria to define HLA haplotype loss in human solid tumors

1 reference

12 December 2020

Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer

1 reference

12 December 2020

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

12 December 2020

Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue

1 reference

12 December 2020

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

12 December 2020

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

1 reference

12 December 2020

High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines

1 reference

12 December 2020

Natural history of HLA expression during tumour development.

1 reference

12 December 2020

The beta2-microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon

1 reference

12 December 2020

In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele

1 reference

12 December 2020

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

1 reference

12 December 2020

HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer

1 reference

12 December 2020

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

1 reference

12 December 2020

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors

1 reference

12 December 2020

High frequency of altered HLA class I phenotypes in laryngeal carcinomas

1 reference

12 December 2020

Molecular basis of human natural killer cell recognition of HLA-E (human leucocyte antigen-E) and its relevance to clearance of pathogen-infected and tumour cells

1 reference

12 December 2020

TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide

1 reference

12 December 2020

HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences

1 reference

12 December 2020

Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy.

1 reference

12 December 2020

Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells

1 reference

12 December 2020

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

12 December 2020

HLA class I antigen abnormalities and immune escape by malignant cells.

1 reference

12 December 2020

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

12 December 2020

Molecular strategies to define HLA haplotype loss in microdissected tumor cells

1 reference

12 December 2020

Differences among various class I molecules in competition for beta2m in vivo

1 reference

12 December 2020

10.1007/S00251-002-0526-9

Identifiers

DOI

0 references

1 reference